Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 May 2020 | Story Marcus Maphile | Photo Supplied
Marcus Maphile

The African continent is known for endless wars, extreme poverty, under-development, and highly contested borders left by the legacy of colonialism. Low levels of literacy among young people and adults remain a concern in many African states. African universities are slowly beginning to play a significant role in contributing to national innovation systems that seek to change the socio-economic and other fortunes of many poor and marginalised Africans. 

The African continent celebrates the 57th anniversary of the founding of the Organisation of African Unity (OAU), and the relevance of the current African Union (AU) in the fight against socio-economic challenges caused by COVID-19 on the continent. The fear faced by most African countries emanates from inadequate healthcare systems and facilities. The debate on the opening of schools and institutions of higher learning is passed around like a soccer ball, as countries are aware that they lack the capacity to accommodate a surge of COVID-19 infections.

The African higher education and research sector is struggling to adapt. Will they be able to play a significant role towards finding a vaccine, producing new knowledge or research from African indigenous plants?  To be factual, in many ways this is not likely to happen, as most of the higher education institutions struggle with internet connectivity and high data costs. Many books and journals in libraries remain inaccessible, and most will only later record how developed countries moved to online teaching and learning with great success or failure.   All this will happen under the noses of illiterate Africans who rightly expect their higher education and research institutions to contribute towards finding immediate responses to the COVID-19 pandemic threat.

Most public and academic libraries remain closed and there is no word and contribution from highly decorated professionals towards sustaining reading habits and availing relevant materials for research towards finding a vaccine. There is no co-ordinated plan from library ministries and or library lobby groups. This is the context in which Africa Month 2020 is celebrated. It will be remembered as the year in which the promotion of reading and the opening of schools took a beating.

Marcus Maphile is Assistant Director: Library Marketing at the University of the Free State and he writes in his personal capacity.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept